Finny logo
Dibs:
Dibs:
0

BIB vs LABU

Both BIB and LABU are ETFs. BIB has a lower 5-year return than LABU (17.85% vs 18.81%). BIB has a lower expense ratio than LABU (0.95% vs 1.02%). Below is the comparison between BIB and LABU.

BIB LABU
Security Type ETF ETF
Segment Leveraged Equity: U.S. Biotech Leveraged Equity: U.S. Biotech
Family ProShares Direxion
Net Assets $283.20M $779.00M
Expense Ratio 0.95% 1.02%
Management Style passive (index-based) passive (index-based)
Dividend Yield 0.00% 0.00%
Underlying Index NASDAQ Biotechnology Index S&P Biotechnology Select Industry Index
YTD Return 11.23% -25.73%
1-Year Return 52.64% 78.87%
3-Year Return 18.74% -8.56%
5-Year Return 17.85% 18.81%
10-Year Return 26.64% 0.00%

BIB description

The Fund seeks daily investment results, before fees and expenses, that correspond to two times the return of the Nasdaq Biotechnology Index. The Index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical.

BIB performance & returns

YTD Return 11.23%
1-Month Return 19.55%
3-Month Return 6.65%
1-Year Return 52.64%
3-Year Return 18.74%
5-Year Return 17.85%
10-Year Return 26.64%
BIB expense ratio is 0.95%.

BIB holdings

Top 10 Holdings (128.41% of Total Assets)

Name Symbol % Assets
Nasdaq Biotechnology Index Swap Bank Of America Na N/A 25.20%
Ishares Biotech (Ibb) Swap Goldman Sachs International N/A 19.46%
Nasdaq Biotechnology Index Swap Societe Generale N/A 18.42%
Nasdaq Biotechnology Index Swap Ubs Ag N/A 17.59%
Ishares Biotech (Ibb) Swap Bank Of America Na N/A 12.00%
Nasdaq Biotechnology Index Swap Citibank Na N/A 9.98%
Nasdaq Biotechnology Index Swap Credit Suisse International N/A 9.07%
Nasdaq Biotechnology Index Swap Goldman Sachs International N/A 5.86%
Gilead Sciences Inc GILD 5.46%
Amgen Inc AMGN 5.37%

Other relevant BIB comparisons

You may also want to check out the following BIB comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

LABU description

The Fund seeks daily investment results of 300% of the performance of the S&P Biotechnology Select Industry Index. The Fund creates long positions by investing at least 80% of its assets in the securities that comprise the Index and/or financial instruments that provide leveraged and unleveraged exposure to the Index.

LABU performance & returns

YTD Return -25.73%
1-Month Return 25.09%
3-Month Return -29.01%
1-Year Return 78.87%
3-Year Return -8.56%
5-Year Return 18.81%
10-Year Return 0.00%
LABU expense ratio is 1.02%.

LABU holdings

Top 10 Holdings (43.64% of Total Assets)

Name Symbol % Assets
Dreyfus Government Secs Cash Mgmt Admin DAPXX 23.88%
Goldman Sachs FS Treasury Intms Instl FTIXX 14.29%
S&P Biotechnology Select Industry Index Swap N/A 1.05%
Arrowhead Pharmaceuticals Inc ARWR 0.82%
Mirati Therapeutics Inc MRTX 0.78%
Exact Sciences Corp EXAS 0.77%
Blueprint Medicines Corp BPMC 0.73%
Arcturus Therapeutics Holdings Inc ARCT 0.66%
Amicus Therapeutics Inc FOLD 0.66%

Other relevant LABU comparisons

You may also want to check out the following LABU comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.
Follow Us